POU4F1
Identifiers
Aliases	POU4F1, BRN3A, Oct-T1, RDC-1, brn-3A, POU class 4 homeobox 1, ATITHS
External IDs	OMIM: 601632; MGI: 102525; HomoloGene: 21255; GeneCards: POU4F1; OMA:POU4F1 - orthologs
Gene location (Human) Chr. Chromosome 13 (human)[1] Band 13q31.1 Start 78,598,362 bp[1] End 78,603,552 bp[1]
RNA expression pattern Bgee Human Mouse (ortholog) Top expressed in secondary oocyte spinal ganglia testicle trigeminal ganglion buccal mucosa cell gonad tibialis anterior muscle pancreatic ductal cell Medulla Oblongata deltoid muscle n/a More reference expression data BioGPS More reference expression data
Gene ontology Molecular function RNA polymerase II cis-regulatory region sequence-specific DNA binding DNA binding DNA-binding transcription factor activity DNA-binding transcription activator activity, RNA polymerase II-specific transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding chromatin binding single-stranded DNA binding sequence-specific DNA binding GTPase binding transcription coactivator activity transcription corepressor activity DNA-binding transcription factor activity, RNA polymerase II-specific Cellular component neuron projection nucleoplasm nucleus cytoplasm Biological process peripheral nervous system neuron development regulation of transcription, DNA-templated habenula development axonogenesis trigeminal nerve development neuron fate specification ventricular compact myocardium morphogenesis cell migration in hindbrain negative regulation of apoptotic process negative regulation of transcription by RNA polymerase II transcription by RNA polymerase II transcription, DNA-templated nervous system development multicellular organism development negative regulation of transcription elongation by RNA polymerase I central nervous system neuron differentiation neuron differentiation positive regulation of apoptotic process synapse assembly peripheral nervous system neuron differentiation mesoderm development innervation proprioception involved in equilibrioception regulation of neurogenesis sensory system development suckling behavior regulation of signal transduction by p53 class mediator positive regulation of gene expression neuron projection development negative regulation of neuron apoptotic process positive regulation of transcription by RNA polymerase II negative regulation of programmed cell death positive regulation of osteoclast differentiation regulation of DNA-binding transcription factor activity cellular response to cytokine stimulus cellular response to estradiol stimulus intrinsic apoptotic signaling pathway by p53 class mediator positive regulation of transcription regulatory region DNA binding heart development negative regulation of gene expression Sources:Amigo / QuickGO
Orthologs Species Human Mouse Entrez 5457 18996 Ensembl ENSG00000152192 ENSMUSG00000048349 UniProt Q01851 P17208 RefSeq (mRNA) NM_006237 NM_011143 RefSeq (protein) NP_006228 NP_035273 Location (UCSC) Chr 13: 78.6 – 78.6 Mb n/a PubMed search [2] [3]
Wikidata
View/Edit Human View/Edit Mouse

POU domain, class 4, transcription factor 1 (POU4F1) also known as brain-specific homeobox/POU domain protein 3A (BRN3A), homeobox/POU domain protein RDC-1 or Oct-T1 is a protein that in humans is encoded by the POU4F1 gene.^[4][5]

BRN3A (POU4F1) is a class IV POU domain-containing transcription factor highly expressed in the developing peripheral sensory nervous system (dorsal root ganglia, trigeminal ganglion, and hindbrain sensory ganglia), certain regions of the central nervous system, retinal neurons called ganglion cells, and in cells of the B- and T-lymphocytic lineages.^[5][6]

Brn3a was initially discovered in mice based on homology to the prototypal POU transcription factors Pit1 (Pituitary-specific positive transcription factor 1, Pou1f1), Oct1 (Pou2f1), and the Caenorhabditis elegans factor Unc86, and named Brn3.^[7] When multiple members of the Brn3 gene class were discovered, it was renamed Brn3.0 and Brn3a by different groups of researchers.^[6][8] Subsequently, the gene was systematically renamed Pou4f1 in mice and POU4F1 in humans. The protein product is still frequently referred to as Brn3a.

In addition to sensory neurons, in rodents and birds (and presumably humans) Brn3a is expressed in multiple sites in the central nervous system, including the spinal cord, midbrain superior colliculus, red nucleus, nucleus ambiguus, inferior olivary nucleus, habenula, and retina.^[9]

Mice with null mutations ("knockouts") in Brn3a die at birth, due to developmental defects in the nucleus ambiguus, which is essential for respiration.^[10][11][12]

Brn3a is a transcription factor which acts in development by regulating downstream "target" genes. Microarrays have been used to determine many genes downstream of Brn3a in peripheral sensory neurons.^[13][14]

In the sensory neurons Brn3a is co-expressed with the LIM domain transcription factor ISL1 or Islet1, and has many downstream targets in common with Isl1.^[15] Pou4f1/Isl1 double mutant mice show strong epistatic effects in regulation of many downstream genes in the sensory neurons of double mutant mouse embryos.^[16]

Although the homozygous Brn3a null mutation is lethal at birth in mice, Brn3a null heterozygotes have no known phenotype. i.e. the Brn3a null mutation is completely recessive. This can be explained by gene dosage compensation due to autoregulation,^[17] in which expression of the remaining copy of the Pou4f1 gene is increased in heterozygotes, leading to near-normal expression of its downstream targets.^[13] The combination of homozygote lethality and dosage compensation in heterozygotes may explain why POU4F1 mutations have not been identified in any human disease, whereas diseases are associated with several other members of the POU domain transcription factor class.

POU4F1 has been shown to interact with Estrogen receptor alpha,^[18] RIT2^[19] and Ewing sarcoma breakpoint region 1.^[20]

• BRN-3

• POU4F1+protein,+human at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

This article incorporates text from the United States National Library of Medicine, which is in the public domain.